1. Home
  2. OPRA vs RAPP Comparison

OPRA vs RAPP Comparison

Compare OPRA & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Opera Limited

OPRA

Opera Limited

HOLD

Current Price

$14.14

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

RAPP

Rapport Therapeutics Inc.

HOLD

Current Price

$26.92

Market Cap

1.2B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
OPRA
RAPP
Founded
1996
2022
Country
Norway
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
2018
2024

Fundamental Metrics

Financial Performance
Metric
OPRA
RAPP
Price
$14.14
$26.92
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$23.50
$47.80
AVG Volume (30 Days)
637.2K
427.2K
Earning Date
02-26-2026
11-06-2025
Dividend Yield
5.68%
N/A
EPS Growth
N/A
N/A
EPS
0.90
N/A
Revenue
$583,449,000.00
N/A
Revenue This Year
$27.78
N/A
Revenue Next Year
$14.95
N/A
P/E Ratio
$15.67
N/A
Revenue Growth
30.29
N/A
52 Week Low
$12.62
$6.43
52 Week High
$22.50
$42.27

Technical Indicators

Market Signals
Indicator
OPRA
RAPP
Relative Strength Index (RSI) 49.92 42.60
Support Level $13.13 $26.30
Resistance Level $14.77 $28.10
Average True Range (ATR) 0.48 1.80
MACD -0.05 -0.37
Stochastic Oscillator 47.09 20.07

Price Performance

Historical Comparison
OPRA
RAPP

About OPRA Opera Limited

Opera Ltd is a world-wide internet brand with a large, engaged, and growing base. It offers users products and services that include a variety of PC and mobile browsers, Opera Gaming portals and development tools, Opera News content recommendation products, and a number of e-commerce products and services. Its browser's features include tabbed browsing, data savings, PC/mobile sync, and numerous features focused on privacy and security, including ad blocking and a built-in VPN. Its browser products include Opera Mini, Opera Browser for Android and iOS, Opera for Computers, Opera GX and Opera GX Mobile, separate browsers tailored for gamers. Geographically, the company generates maximum revenue from the United States, followed by Singapore, Nigeria, Russia, and other locations.

About RAPP Rapport Therapeutics Inc.

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Share on Social Networks: